For: | Tripathi K, Goel A, Singhai A, Garg M. Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder. World J Clin Oncol 2020; 11(8): 614-628 [PMID: 32879848 DOI: 10.5306/wjco.v11.i8.614] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i8/614.htm |
Number | Citing Articles |
1 |
Ti-Chun Chan, Yow-Ling Shiue, Chien-Feng Li. The biological impacts of CEBPD on urothelial carcinoma development and progression. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1123776
|
2 |
Pratishtha Gupta, Niraj Kumar, Minal Garg. Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder. Expert Opinion on Therapeutic Targets 2021; 25(9): 787 doi: 10.1080/14728222.2021.1992384
|
3 |
Richard L. Pullen. Bladder cancer. Nursing 2024; 54(4): 27 doi: 10.1097/01.NURSE.0001007608.96581.fa
|
4 |
Jidong Zhao, Xiangmei Zhang, Ming He, Xin Chen, Xing Cui, Tian Qin, Xueliang Niu, Liyan Zhao. Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation. OncoTargets and Therapy 2021; : 1113 doi: 10.2147/OTT.S295813
|
5 |
Kiran Tripathi, Apul Goel, Atin Singhai, Minal Garg. Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder. Molecular Biology Reports 2021; 48(3): 2183 doi: 10.1007/s11033-021-06227-x
|